BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Shareholder Equity 2019–2025
BridgeBio Pharma, Inc. annual shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- BridgeBio Pharma, Inc. shareholder equity as of December 31, 2025: -2.09B, a 42.15% increase year-over-year.
- BridgeBio Pharma, Inc. shareholder equity for 2025 were -2.09B, a 42.15% increase from 2024.
- BridgeBio Pharma, Inc. shareholder equity for 2024 were -1.47B, a 8.39% increase from 2023.
- BridgeBio Pharma, Inc. shareholder equity for 2023 were -1.35B, a 7.94% increase from 2022.
- BridgeBio Pharma, Inc. shareholder equity for 2022 were -1.25B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BridgeBio Pharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-2,087 |
| 2024 | $-1,468 |
| 2023 | $-1,354 |
| 2022 | $-1,255 |
| 2021 | $-870 |
| 2020 | $58 |
| 2019 | $408 |
BridgeBio Pharma, Inc. Shareholder Equity — FAQ
BridgeBio Pharma, Inc. (BBIO) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's shareholder equity history?
The chart and table above show BridgeBio Pharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.